Literature DB >> 10328095

The new melanoma markers: MART-1 and Melan-A (the NIH experience)

P A Fetsch, F M Marincola, A Abati.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10328095     DOI: 10.1097/00000478-199905000-00017

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


× No keyword cloud information.
  6 in total

1.  Immunoblot analysis of CD34 expression in histologically diverse neoplasms.

Authors:  Y Natkunam; R V Rouse; S Zhu; C Fisher; M van De Rijn
Journal:  Am J Pathol       Date:  2000-01       Impact factor: 4.307

Review 2.  [Endocrine tumors of the testis].

Authors:  V Loy; J Linke
Journal:  Pathologe       Date:  2003-05-13       Impact factor: 1.011

3.  Marginal and joint distributions of S100, HMB-45, and Melan-A across a large series of cutaneous melanomas.

Authors:  Hollis Viray; William R Bradley; Kurt A Schalper; David L Rimm; Bonnie E Gould Rothberg
Journal:  Arch Pathol Lab Med       Date:  2013-08       Impact factor: 5.534

4.  MLANA/MART1 and SILV/PMEL17/GP100 are transcriptionally regulated by MITF in melanocytes and melanoma.

Authors:  Jinyan Du; Arlo J Miller; Hans R Widlund; Martin A Horstmann; Sridhar Ramaswamy; David E Fisher
Journal:  Am J Pathol       Date:  2003-07       Impact factor: 4.307

5.  Human endogenous retrovirus K triggers an antigen-specific immune response in breast cancer patients.

Authors:  Feng Wang-Johanning; Laszlo Radvanyi; Kiera Rycaj; Joshua B Plummer; Peisha Yan; K Jagannadha Sastry; Chandrika J Piyathilake; Kelly K Hunt; Gary L Johanning
Journal:  Cancer Res       Date:  2008-07-15       Impact factor: 12.701

Review 6.  An Algorithmic Immunohistochemical Approach to Define Tumor Type and Assign Site of Origin.

Authors:  Andrew M Bellizzi
Journal:  Adv Anat Pathol       Date:  2020-05       Impact factor: 4.571

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.